AVNS Avanos Medical Inc
Price (delayed)
$12.35
Market cap
$568.14M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$8.53
Enterprise value
$630.64M
Avanos Medical, Inc. is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address
Highlights
The quick ratio has increased by 48% year-on-year and by 39% since the previous quarter
Avanos Medical's debt has decreased by 19% YoY and by 16% from the previous quarter
The company's equity fell by 33% YoY and by 33% QoQ
Key stats
What are the main financial stats of AVNS
Market
Valuations
Earnings
Shares outstanding
46M
Market cap
$568.14M
Enterprise value
$630.64M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.69
Price to sales (P/S)
0.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.92
Revenue
$687.8M
Gross profit
$381.3M
Operating income
-$400.1M
Net income
-$392.1M
EBIT
-$396.9M
EBITDA
-$351.4M
Free cash flow
$82.9M
Per share
Balance sheet
Liquidity
EPS
-$8.53
EPS diluted
-$8.53
Free cash flow per share
$1.8
Book value per share
$18.03
Revenue per share
$14.97
TBVPS
$12.76
Total assets
$1.15B
Total liabilities
$325.7M
Debt
$170.2M
Equity
$828.5M
Working capital
$227.5M
Debt to equity
0.21
Current ratio
2.37
Quick ratio
1.45
Net debt/EBITDA
-0.18
Margins
Efficiency
Dividend
EBITDA margin
-51.1%
Gross margin
55.4%
Net margin
-57%
Operating margin
-58.2%
Return on assets
-25.6%
Return on equity
-34.8%
Return on invested capital
-74%
Return on capital employed
-40.2%
Return on sales
-57.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AVNS stock price
How has the Avanos Medical stock price performed over time
Intraday
-1.44%
1 week
-0.64%
1 month
-12.6%
1 year
-30.81%
YTD
-22.42%
QTD
-13.82%
Financial performance
How have Avanos Medical's revenue and profit performed over time
Revenue
$687.8M
Gross profit
$381.3M
Operating income
-$400.1M
Net income
-$392.1M
Gross margin
55.4%
Net margin
-57%
The revenue is up by 2.2% year-on-year
Growth
What is Avanos Medical's growth rate over time
Valuation
What is Avanos Medical stock price valuation
P/E
N/A
P/B
0.69
P/S
0.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.92
AVNS's price to book (P/B) is 37% less than its 5-year quarterly average of 1.1 and 14% less than its last 4 quarters average of 0.8
The company's equity fell by 33% YoY and by 33% QoQ
The P/S is 59% lower than the 5-year quarterly average of 2.0 and 36% lower than the last 4 quarters average of 1.3
The revenue is up by 2.2% year-on-year
Efficiency
How efficient is Avanos Medical business performance
Dividends
What is AVNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AVNS.
Financial health
How did Avanos Medical financials performed over time
The quick ratio has increased by 48% year-on-year and by 39% since the previous quarter
The total assets has contracted by 32% YoY and by 30% from the previous quarter
Avanos Medical's debt is 79% less than its equity
The company's equity fell by 33% YoY and by 33% QoQ
The debt to equity has grown by 31% from the previous quarter and by 24% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.